1
Material Type:
Newsletter Articles
Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors
PR Newswire, 2023
New York: PR Newswire Association LLC
Sem texto completo
2
Material Type:
Newsletter Articles
Health & Medicine Week, 2022, p.3344
NewsRX LLC
Texto completo disponível
3
Material Type:
Newsletter Articles
Vaccine Weekly, 2020, p.40
Atlanta: NewsRx
Texto completo disponível
4
Material Type:
Newsletter Articles
Immunotherapy Weekly, 2023, p.1178
NewsRX LLC
Texto completo disponível
5
Material Type:
Newsletter Articles
Immunotherapy Weekly, 2020, p.5444
NewsRX LLC
Texto completo disponível
6
Material Type:
Newsletter Articles
Drug Week, 2019, p.2190
Atlanta: NewsRx
Texto completo disponível
7
Material Type:
Newsletter Articles
Cancer Weekly, 2023, p.410
NewsRX LLC
Texto completo disponível
8
Material Type:
Newsletter Articles
Immunotherapy Weekly, 2023, p.6757
NewsRX LLC
Texto completo disponível
9
Material Type:
Newsletter Articles
Drug Week, 2019, p.3411
Atlanta: NewsRx
Texto completo disponível
10
Material Type:
Newsletter Articles
Politics & Government Week, 2020, p.393
NewsRX LLC
Texto completo disponível